Skip to Main Content
Contribute Try STAT+ Today

First, health care entrepreneurs raced to claim the market to put an EKG on consumer’s wrists. Then came miniaturized glucose monitors and tracking devices inside chemotherapy pills. Now, the rush is on to tackle the most personally intrusive, and impactful, task of all: Embedding sensors all along your digestive tract.

Around the world, researchers are developing ingestible sensors designed to help detect and treat everything from colon cancer, to minor indigestion, to Crohn’s disease, while potentially unlocking some of the biggest mysteries buried in the human gut.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.